Press Release

Trelli Launches Relivaid, Bringing Clinically Validated Bioavailability Technology to Naturally Derived Pain Relief

Science-first brand Trelli launches with the mission to rebuild the medicine cabinet with better-for-you solutions, starting with Relivaid – a pain support formula engineered for single-dose efficacy, relief in minutes, and a naturally derived ingredient profile for strength and safety.

Hand holding Trelli's Relivaid supplement
New York, NY / Apr 14, 2026 / Trelli

Trelli enters the consumer health market with a clear point of view: the medicine cabinet is overdue for better options. For decades, conventional pain relief has remained largely unchanged. The same active ingredients, the same delivery mechanisms, the same trade-offs. As consumers increasingly scrutinize what they put in their bodies and how often, a category built on familiarity has had little to offer in the way of progress.

Founded alongside a medical advisory board with ties to Harvard Medical School, Scripps Integrative Medicine, Nutrafol, and Thorne, Trelli brings a formulation standard largely absent from consumer wellness. Every ingredient is selected based on human clinical research, dosed to therapeutic levels, and where needed, optimized using advanced pharmaceutical delivery technology to ensure active compounds reach the body at the concentrations required to perform.

Relivaid is the first product to come out of that standard. A fast-acting, single-dose pain support formula targeting tension headaches, menstrual cramps, joint and muscle aches, and general inflammation, it is built around three naturally derived bioactives. Each is chosen for a specific and documented mechanism of action, with advanced delivery systems applied at the ingredient level for absorption, speed, and complementary effect.

“Consumers are taking more OTC products than ever before, and the side effects and risks that come with long-term use are very real,” said Luke Lundstrom, founder of Trelli. “Trelli was born out of my own experience, after having a GI bleed from ibuprofen overuse. We wanted to build something where you don’t have to choose between effective relief and long-term health.”

Relivaid is the first of what Trelli intends to be a broader suite of better-for-you medicine cabinet solutions, each held to the same standard: naturally derived, clinically grounded, and built for people who want relief they can feel good about.

Relivaid is available exclusively at trelli.health beginning April 14, 2026.

###
About Trelli

Trelli is a science-first consumer health company founded by Luke Lundstrom after experiencing firsthand the limitations and risks of conventional OTC solutions. Born from a belief that naturally derived ingredients, when formulated with true clinical rigor, can deliver the fast-acting relief people actually need, Trelli set out to rebuild the medicine cabinet from the ground up.

Trelli believes that better-for-you and effective are not a trade-off. Every product is developed alongside a medical advisory board of physicians, researchers, registered dietitians, and biomolecular scientists and every ingredient is clinically studied, dosed to therapeutic levels, and optimized using advanced delivery technology for fast-acting relief.

Press Contact
press@trelli.health
Trelli
Strategic intelligence for the future of health.

We break down how fitness, wellness, and healthcare are converging — and what it means for business, culture, and capital.

No thanks.